NCT04336241 2026-02-27Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid TumorsReplimune Inc.Phase 1 Active not recruiting36 enrolled
NCT03025256 2026-01-08Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal DiseaseM.D. Anderson Cancer CenterPhase 1 Active not recruiting71 enrolled
NCT02831933 2023-09-21ENSIGNThe Methodist Hospital Research InstitutePhase 2 Terminated11 enrolled 9 charts